Gastroesophageal Reflux Disease (GERD): Current Agents and Future Perspective

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|7|1|1-18

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.7, Iss.1, 2001-01, pp. : 1-18

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

An Evidence-based Review of Medicinal Herbs for the Treatment of Gastroesophageal Reflux Disease (GERD)

By  

Current Drug Discovery Technologies, Vol. 15, Iss. 4, 2018-12 ,pp. : 305-314

Bentham Science Publishers

Access to resources Recommend Favorite

Assessment of Airway Inflammation by Exhaled Breath Condensate and Impedance Due to Gastroesophageal Reflux Disease (GERD)

By  

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 8, Iss. 4, 2009-09 ,pp. : 292-296

Bentham Science Publishers

Access to resources Recommend Favorite

The Work Productivity and Activity Impairment Questionnaire for Patients with Gastroesophageal Reflux Disease (WPAI-GERD): Responsiveness to Change and English Language Validation

By Wahlqvist Peter  

PharmacoEconomics, Vol. 25, Iss. 5, 2007-01 ,pp. : 385-396

Adis International

Access to resources Recommend Favorite

Treatment of Gastroesophageal Reflux Disease*

By Pettit Michael  

Pharmacy World and Science, Vol. 27, Iss. 6, 2005-12 ,pp. : 432-435

Springer Publishing Company

Access to resources Recommend Favorite

Mechanisms of Esophageal Protection, Gastroprotection and Ulcer Healing by Melatonin. Implications for the Therapeutic use of Melatonin in Gastroesophageal Reflux Disease (GERD) and Peptic Ulcer Disease

By  

Current Pharmaceutical Design, Vol. 20, Iss. 30, 2014-01 ,pp. : 4807-4815

Bentham Science Publishers

Access to resources Recommend Favorite